Guidance Capital’s Vertex Pharmaceuticals VRTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $898K | Sell |
1,943
-332
| -15% | -$153K | 0.26% | 92 |
|
|
2025
Q1 | $1.14M | Buy |
2,275
+174
| +8% | +$87.2K | 0.35% | 53 |
|
|
2024
Q4 | $924K | Buy |
2,101
+395
| +23% | +$174K | 0.28% | 71 |
|
|
2024
Q3 | $824K | Buy |
1,706
+150
| +10% | +$72.5K | 0.26% | 95 |
|
|
2024
Q2 | $771K | Buy |
1,556
+149
| +11% | +$73.9K | 0.25% | 89 |
|
|
2024
Q1 | $559K | Buy |
1,407
+24
| +2% | +$9.54K | 0.21% | 109 |
|
|
2023
Q4 | $568K | Buy |
1,383
+312
| +29% | +$128K | 0.23% | 98 |
|
|
2023
Q3 | $370K | Buy |
1,071
+49
| +5% | +$16.9K | 0.17% | 108 |
|
|
2023
Q2 | $358K | Buy |
+1,022
| New | +$358K | 0.16% | 116 |
|